Studies related to Symptoms of Alzheimer’s and Saffron

A 22-week, Multicenter, Randomized, Double-blind Controlled Trial Of Crocus Sativus In The Treatment Of Mild-to-moderate Alzheimer's Disease

Effect None
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 47
Sex Both Genders
Age Range 65+
Notes for this study:
Supplementation of 15mg saffron extract twice daily over the course of 18 weeks (with a 4 week run in period with 15mg once daily) in persons with Alzheimer's disease failed to see significant benefits relative to either the reference drug (donepezil at 10mg) or to baseline on ADAS-cog or CDR-SB. No placebo control was used in this study.

Full details on all 3 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.